RE:New tech for skin careEveryone has a product to improve beauty/skin etc
It all boils down to hard objective results with clinical backing. The results, if impressed will drive the enterprise value as the compound is Novel, meaning there is nothing like it on the market. It is 100% Sirona invention.
On that front I think the value of anti-aging will be correlated to the effectiveness to impact/rebuild the subdermal and dermal layers. Photos would be helpful for the average investor to see.
The question is whether the R&D clinical results will be owned and controlled by Sirona and not the other party participating in the clinical. If its owned by them, they then have the full privelege of shopping the deal widely.
If the results are in fact very impressive then that would mean tremendous upside from 11 cents.